CARDIO Flashcards

1
Q

Define Abdominal Aortic Aneurysm (AAA)

A

A localised enlargement of the abdominal aorta such that the diameter is >3cm or >50% larger than the normal diameter

(normal diameter of the aorta is 2cm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aetiology/ Risk Factors for AAA

A
  • no specific identifiable causes
    Risk FACtors:
  • Severe atherosclerotic damage to aortic wall
    -Family history
    -Smoking
    -Male
    -Age
    -Hypertension
    -Hyperlipidaemia
    -Connective tissue disorders: Marfan’s syndrome, Ehlers-Danlos syndrome
    -Inflammatory disorders: Behcet’s disease, Takayasu’s arteritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Presenting symptoms of AAA (ruptured and unruptured)

A
• Unruptured
- NO SYMPTOMS
- Usually an incidental finding
- May have pain in the back, abdomen, loin or groin
• RUPTURED
- Pain in the abdomen, back or loin 
-Pain may be sudden or severe 
-Syncope
-Shock
• NOTE: degree of shock depends on site of rupture and whether it is contained
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs of AAA on physical examination

A
  • pulsatile laterally expansile mass on bimanual palpation of the abdominal aorta
  • abdominal bruit
  • retroperitoneal haemorrhage causes Grey- Turner’s sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations of AAA

A

• Bloods
-FBC, clotting screen, renal function and liver function
-Cross-match if surgery is planned
• Scans
- Ultrasound - can detect aneurysm but CANNOT tell whether it is leaking or not
- CT with contrast - can show whether an aneurysm has ruptured
-MRI angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Aortic Dissection

A

A condition where a tear in the aortic intima allows blood to surge into the aortic wall, causing a split between the inner and outer tunica media, creating a false lumen

  • Classification of aortic dissection :
  • Type A: ascending aorta (most common)
  • Type B: descending aorta (distal to the left subclavian artery )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aetiology/ Risk Factors of aortic dissection

A

• Aortic dissection is usually preceded by degenerative changes in the smooth muscle of
the aortic media
• Common causes and risk factors:
-HYPERTENSION
-Aortic atherosclerosis
- Connective tissue disease (e.g. Marfan’s, Ehlers-Danlos, SLE)
-Congenital cardiac abnormalities (e.g. coarctation of the aorta)
-Aortitis
-Iatrogenic (e.g. during angioplasty/angiography)
-Trauma
-Crack cocaine
• NOTE: expansion of the false lumen can lead to obstruction of the subclavian, carotid, coeliac and renal arteries
Hypoperfusion of the target organs of these major arteries can give rise to other symptoms (e.g. carotid artery –> collapse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiology of aortic dissection

A

most common in males aged 40-60yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Presenting symptoms of aortic dissection

A

• MAIN SYMPTOM: sudden central ‘tearing’ pain, it may radiate to the back in between
the shoulder blades (it can mimic MI)
• Other symptoms caused by obstruction of branches of the aorta:
- Carotid artery –> hemiparesis, dysphasia, blackout
-Coronary artery –> chest pain (angina or MI)
- Subclavian artery –> ataxia, loss of consciousness
- Anterior spinal artery –> paraplegia
-Coeliac axis –> severe abdominal pain (due to ischaemic bowel)
- Renal artery –> anuria, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signs of aortic dissection on physical examination

A
• Murmur on the back (below the left scapula), descending to the abdomen
• Hypertension
• Blood pressure difference between the two arms > 20 mm Hg
• Wide pulse pressure
• Hypotension may suggest tamponade
-Check for pulsus paradoxus = abnormally large decrease in systolic blood pressure and pulse wave amplitude during inspiration
-This may indicate:
• Tamponade
• Pericarditis
• Chronic sleep apnoea
• Obstructive lung disease
• Signs of Aortic Regurgitation
High volume collapsing pulse
Early diastolic murmur over aortic area
• Unequal arm pulses
• There may be a palpable abdominal mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations for aortic dissection

A

• Bloods

  • FBC
  • X-match 10 units of blood
  • U&E - check renal function
  • Clotting screen

• CXR
- Widened mediastinum

• ECG 
- Often NORMAL
- If the ostia of the right coronary artery is compromised you may get signs of:
• Left ventricular hypertrophy
• Inferior MI

• CT Thorax
- Shows false lumen

• Echocardiography
- Transoesophageal allows visualisation

• Cardiac catheterisation and aortography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Aortic Regurgitation

A

Reflux of blood from the aorta into the left ventricle during diastole. Also known as aortic insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aetiology and Risk factors of aortic regurgitation

A
• Aortic valve leaflet abnormalities or damage
- Bicuspid aortic valve 
-Infective endocarditis
- Rheumatic fever 
-Trauma
• Aortic root/ascending aorta dilatation
-Systemic hypertension
- Aortic dissection
- Aortitis
- Arthritides (e.g. rheumatoid arthritis, seronegative arthritides) 
-Connective tissue disease (e.g. Marfan's, Ehlers-Danlos)
- Pseudoxanthoma elasticum
-Osteogenesis imperfecta

• Pathophysiology
Reflux of blood into the left ventricle results in left ventricular dilatation This means increased end diastolic volume and increased stroke volume The combination of increased stroke volume and low end-diastolic AORTIC pressure may explain the high-volume collapsing pulse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Summarise the epidemiology of aortic regurgitation

A
  • Chronic AR beings in the late 50s

- Most frequent in patients >50years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presenting symptoms of aortic regurgitation

A

• Chronic AR
Initially ASYMPTOMATIC
Later on, the patient may develop symptoms of heart failure (e.g. exertional dyspnoea, orthopnoea, fatigue)
• Severe Acute AR
Sudden cardiovascular collapse (left ventricle cannot adapt to the rapid increase
in end-diastolic volume)
• Symptoms related to aetiology (e.g. chest or back pain caused by aortic dissection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Signs of aortic regurgitation on examination

A

• Collapsing (water-hammer) pulse
• Wide pulse pressure
• Thrusting and heaving displaced apex beat
• Early diastolic murmur over the aortic valve region
- Heard better at the left sternal edge when the patient is sitting forward with the
breath held at the top of expiration
• NOTE: an ejection systolic murmur may also be heard because of increased flow across
the valve (due to increased stroke volume)
• Austin Flint mid-diastolic murmur
Heard over the apex
Caused by turbulent reflux hitting the anterior cusp of the mitral valve causing a physiological mitral stenosis
• Rare signs associated with aortic regurgitation:
Quincke’s Sign - visible pulsation on nail bed
de Musset’s Sign - head nodding in time with the pulse
Becker’s Sign - visible pulsation of the pupils and retinal arteries
Muller’s Sign - visible pulsation of the uvula
Corrigan’s Sign - visible pulsation in the neck
Traube’s Sign - pistol shot (loud systolic and diastolic sounds) heard on auscultation of the femoral arteries
Duroziez’s Sign - systolic and diastolic bruit heard on partial compression of the femoral artery with the stethoscope
Rosenbach’s Sign - systolic pulsations of the liver
Gerhard’s Sign - systolic pulsations of the spleen
Hill’s Sign - popliteal cuff systolic pressure exceeding brachial pressure by > 60 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Identify investigations for aortic regurgitation

A
• CXR
- Cardiomegaly
- Dilatation of ascending aorta
- Signs of pulmonary oedema (if accompanied by left heart failure)
• ECG 
- may show left ventricular hypertrophy 
 •deep S in V1/2
 •Tall R in V5/6
 •Inverted T waves in lead 1, aVL, V5/6
 •Left axis deviation

• Echocardiogram
- May show underlying cause (e.g. aortic root dilatation, bicuspid aortic valve)
-May show the effects of aortic regurgitation (e.g. left ventricular dilatation, fluttering of the anterior mitral valve leaflet)
-Doppler echocardiogram can show AR and indicate severity
-Repeat echos allow monitoring of progression (LV size and function)
• Cardiac catheterisation with angiography
- If there is any uncertainty about the functional state of the ventricle or the presence of coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define Aortic Stenosis

A

Narrowing of the left ventricular outflow at the level of the aortic valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Aetiology and risk factors of aortic stenosis

A
  • Stenosis can be secondary to rheumatic heart disease
  • Calcification of a congenital bicuspid aortic valve
  • Calcification/ degeneration of a tricuspid aortic valve in the elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Epidemiology of aortic stenosis

A
  • Present in 3% of 75 yr olds
  • More common in males
  • Those with bicuspid aortic valve present earlier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Presenting symptoms of aortic stenosis

A
  • may be asymptomatic initially
  • angina (due to increased oxygen demand of the hypertrophied left ventricle)
  • syncope or dizziness on exercise (due to outflow obstruction)
  • symptoms of heart failure (e.g. dyspnoea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Signs of aortic stenosis on examination

A
  • Narrow pulse pressure
  • Slow-rising pulse
  • Thrill in the aortic area (only if severe)
  • Forceful sustained thrusting undisplaced apex beat
  • Ejection systolic murmur at the aortic area, radiating to the carotid artery
  • Second heart sound may be softened or absent (due to calcification)
  • A bicuspid valve may produce an ejection click
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Investigations for aortic stenosis

A
• ECG
- Signs of left ventricular hypertrophy: 
  • Deep S in V1/2
  • Tall R in V5/6
  • Inverted T waves in I, aVL and V5/6
  • Left axis deviation
LBBB

• CXR

  • post-stenotic enlargement of ascending aorta
  • calcification of aortic valve

• Echocardiogram

  • Visualises structural changes of the valves and level of stenosis (valvar, supravalvar or subvalvar)
  • Estimation of aortic valve area and pressure gradient across the valve in systole
  • Assess left ventricular function

• Cardiac angiography
- Allows differentiation from other causes of angina (e.g. MI)
- Allows assessment of concomitant coronary artery disease
• NOTE: 50% of patients with severe aortic stenosis have significant coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Define Arterial Ulcer

A

A localised area of damage and breakdown of skin due to inadequate arterial blood supply. Usually seen on the feet of patients with severe atheromatous narrowing of the arteries supplying the legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Aetiology/ Risk factors of arterial ulcers

A

• The ulcers are caused by a lack of blood flow to the capillary beds of the lower extremities
• Risk Factors
-Coronary heart disease
-History of stroke or TIA
-Diabetes Mellitus
- Peripheral arterial disease (e.g. intermittent claudication)
- obesity and immobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Epidemiology of arterial ulcers

A
  • 22% of leg ulcers

* Prevalence increases with age and obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Presenting symptoms of arterial ulcers

A

• Often DISTAL - at the dorsum of the foot or between the toes
• Punched-out appearance
• Often elliptical with clearly defined edges
• The ulcer base contains grey, granulation tissue
• NIGHT PAIN - hallmark of arterial ulcers
- Pain is worse when supine (because arterial blood flow is further reduced when supine)
- Pain is relieved by dangling the affected leg off the end of the bed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Signs of arterial ulcers on physical examination

A
  • Night pain
  • Punched-out appearance
  • Hairlessness
  • Pale skin
  • Absent pulses
  • Nail dystrophy
  • Wasting of calf muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Appropriate investigations for arterial ulcers

A

• Duplex ultrasonography of lower limbs - assess patency of arteries and potential for
revascularisation or bypass surgery
• ABPI
• Percutaneous angiography
• ECG
• Fasting serum lipids, fasting blood glucose and HbA1c (diabetes is a major risk factor)
• FBC - anaemia can worsen the ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Define Atrial Fibrillation/ Flutter

A

Characterised by rapid, chaotic and ineffective atrial electrical conduction. Often subdivided into:

  • permanent
  • persistent
  • paroxysmal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Aetiology & Risk Factors of atrial fibrillation

A

• There may be no identifiable cause
• Secondary causes lead to an abnormal atrial electrical pathway that results in AF
• Systemic Causes:
Thyrotoxicosis, Hypertension, Pneumonia, Alcohol
• Heart Causes:
Mitral valve disease, Ischaemic heart disease, Rheumatic heart disease, Cardiomyopathy, Pericarditis, Sick sinus syndrome, Atrial myxoma
• Lung Causes:
Bronchial carcinoma, PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Epidemiology of atrial fibrillation

A
  • very common in the elderly
  • present in 5% of those >65 years
  • may be paroxysmal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Presenting symptoms of atrial fibrillation

A
  • often asymptomatic
  • palpitations
  • syncope (if low output)
  • symptoms of the cause of AF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Signs of atrial fibrillation on physical examination

A
  • irregularly irregular pulse
  • difference in apical beat and radial pulse
  • check for signs of thyroid disease and valvular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Investigations for atrial fibrillation

A
• ECG
- uneven baseline with absent p waves 
- irregular intervals between QRS complexes 
• Bloods
-Cardiac enzymes
- TFT
- Lipid profile
- U&Es, Mg2+ and Ca2+
• Because there is increased risk of digoxin toxicity with hypokalaemia, hypomagnesaemia and hypercalcaemia
• Echocardiogram
May show:
• Mitral valve disease
• Left atrial dilatation
• Left ventricular dysfunction
• Structural abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Management plan for atrial fibrillation

A

First and foremost, try to treat any reversible causes (e.g. thyrotoxicosis, chest infection) There are TWO main components to AF management:
• RHYTHM CONTROL
-If > 48 hrs since onset of AF:
• Anticoagulate for 3-4 weeks before attempting cardioversion
-If < 48 hrs since onset of AF:
• DC cardioversion (2 x 100 J, 1 x 200 J)
• Chemical cardioversion: flecainide or amiodarone
NOTE: flecainide is contraindicated if there is a history of ischaemic heart disease
-Prophylaxis against AF
• Sotalol
• Amiodarone
• Flecainide
• Consider pill-in-the-pocket (single dose of a cardioverting drug (e.g.
flecainide) for patients with paroxysmal AF) strategy for suitable patients

• RATE CONTROL
Chronic (Permanent) AF
• Control ventricular rate with: -Digoxin
- Verapamil
-Beta-blockers
Aim for ventricular rate of roughly 90bpm

• STROKE RISK STRATIFICATION:
-LOW RISK patients can be managed with aspirin
-HIGH RISK patients require anticoagulation with warfarin
-This is based on the CHADS-Vasc Score
Risk factors include:
• Previous thromboembolic event
• Age>75yrs
• Hypertension
• Diabetes
• Vascular disease
• Valvular disease
• Heart failure
• Impaired left ventricular function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Complications of atrial fibrillation

A

• THROMBOEMBOLISM
-Embolic stroke risk of 4% per year
-Risk is increased with left atrial enlargement or left ventricular dysfunction
• Worsening of existing heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Summarise the prognosis for patients with atrial fibrillation

A

• Chronic AF in a disease heart does not usually return to sinus rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Define Cardiac Arrest

A

Acute cessation of cardiac function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Explain the aetiology and risk factors of cardiac arrest

A

The REVERSIBLE causes of cardiac arrest can be summarised as the 4 Hs and 4 Ts
• FOUR Ts
- Toxins (and other metabolic disorders (drugs, therapeutic agents, sepsis))
- Thromboembolic
- Tamponade
- Tension pneumothorax

• FOUR Hs

  • Hypothermia
  • Hypoxia
  • Hypovolaemia
  • Hypokalaemia/Hyperkalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Recognise the presenting symptoms of cardiac arrest

A
  • management precedes or is concurrent to history

- usually sudden but some symptoms that me precede are fatigue, fainting, blackouts and dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Signs of cardiac arrest on physical examination

A
  • Unconscious
  • Not breathing
  • Absent carotid pulses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Investigations for cardiac arrest

A
• Cardiac Monitor
- Allows classification of the rhythm
• Bloods
- ABG
- U&amp;E
- FBC
- X-match
- Clotting 
-Toxicology screen 
- Blood glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Generate a management plan for cardiac arrest

A

• SAFETY IS IMPORTANT
- Approach any arrest scene with caution
- The cause of the arrest may pose a threat
-Defibrillators and oxygen are hazards
• Basic Life Support
-If the arrest is witnessed and monitored, consider giving a precordial thump (thump the sternum of the patient with the ulnar aspect of your fist)
-Clear and maintain the airway with head tilt, jaw thrust and chin lift
-Assess breathing by look, listen and feel
• If they are not breathing, give two rescue breaths
-Assess circulation at carotid pulse for 10 seconds
• If absent - give 30 chest compressions at around 100/min
• Continue cycle of 30 chest compressions for every 2 rescue breaths Proceed to advanced life support as soon as possible
• Advanced Life Support
-Attach cardiac monitor and defibrillator
-Assess rhythm
• If pulseless ventricular tachycardia or ventricular fibrillation (shockable rhythms)
- Defibrillate once(150-360 J biphasic, 360J monophasic)
• Make sure no one is touching the patient or the bed
- Resume CPR immediately for 2 minutes and then reassess rhythm, and shock again if still in pulseless VT or VF
- Administer adrenaline(1mgIV) after second defibrillation and again every 3-5 mins
•If shockable rhythm persists after 3rd shock-administer amiodarone 300 mg IV bolus (or lidocaine)
•If pulseless electrical activity (PEA) or asystole (non-shockable rhythms) :
- CPRfor2,and then reassess rhythm
- Administe radrenaline (1mgIV) every3-5mins
- Atropine (3mgIV, once only) if asystole or PEA with rate <60bpm
During CPR:
• Check electrodes, paddle positions and contacts
• Secure airway
- Once secure, give continuous compressions and breaths
• Consider magnesium, bicarbonate and external pacing
• Stop CPR and check pulse only if change in rhythm or signs of life

Treatment of reversible causes:

  • Hypothermia : warm slowly
  • Hypokalaemia and hyperkalaemia : correction of electrolyte levels
  • hypovolaemia : IV colloids, crystalloids and blood products
  • tamponade :pericardiocentesis
  • tension pneumothorax - aspiration or chest drain
  • thromboembolism : treat as PE or MI
  • toxins : use antidote for toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Possible complications of cardiac arrest

A
  • irreversible hypoxic brain damage

- death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Summarise the prognosis for patients with cardiac arrest

A
  • resuscitation is less successful if cardiac arrest happens outside the hospital
  • increased duration of inadequate effective cardiac output –> poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Define Cardiac failure

A

inability of the cardiac output to meet the body’s demands despite normal venous pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Aetiology and risk factors of cardiac failure

A
• LOW OUTPUT Cardiac Failure (reduced cardiac output)
- Left Heart Failure
• Ischaemic heart disease
• Hypertension
• Cardiomyopathy
• Aortic valve disease
• Mitral regurgitation 
  • Right Heart Failure
    • Secondary to left heart failure (in which case it is called congestive cardiac failure)
    • Infarction
    • Cardiomyopathy
    • Pulmonary hypertension/ embolus/ valve disease
    • Chronic lung disease
    • Tricuspid regurgitation
    • Constrictive pericarditis/ pericardial tamponade
-Biventricular Failure
• Arrhythmia
• Cardiomyopathy (dilated or restrictive)
• Myocarditis
• Drug toxicity

• HIGH OUTPUT Cardiac Failure (increased demand)

  • Anaemia
  • Beri beri
  • Pregnancy
  • Paget’s disease
  • Hyperthyroidism
  • Arteriovenous malformation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Epidemiology of cardiac failure

A

10% >65 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Presenting symptoms of cardiac failure

A
• Left Heart Failure - symptoms caused by pulmonary congestion
- Dyspnoea : divided based on the New York Heart Association classification:
• 1 - no dyspnoea
• 2 - dyspnoea on ordinary activities
• 3 - dyspnoea on less than ordinary activities
• 4 - dyspnoea at rest 
-Orthopnoea
-Paroxysmal nocturnal dyspnoea 
- Fatigue
• Acute Left Ventricular Failure
- Dyspnoea
- Wheeze
- Cough
- Pink frothy sputum
• Right Heart Failure
- Swollen ankles
- Fatigue
- Increased weight (due to oedema) 
-Reduced exercise tolerance 
-Anorexia
-Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Signs of cardiac failure on physical examination

A

• Left Heart Failure

  • Tachycardia
  • Tachypnoea
  • Displaced apex beat
  • Bilateral basal crackles
  • S3 gallop (caused by rapid ventricular filling)
  • Pansystolic murmur (due to functional mitral regurgitation)

• Acute Left Ventricular Failure
-Tachypnoea
-Cyanosis
-Tachycardia
-Peripheral shutdown
-Pulsus alternans
• Arterial pulse waveforms showing alternating strong and weak beats
• Sign of left ventricular systolic impairment
• Explanation:
- In left ventricular dysfunction, ejection fraction significantly decreases leading to a reduction in stroke volume
- This causes an increase in end-diastolic volume
- This means that the left ventricle is stretched more for the next contraction
- This results in a stronger systolic pulse
- Due to Starling’s Law, the increased stretch of the left ventricle
caused by the increased end-diastolic volume following the previous beat leads to an increase in the strength of the myocardial contraction
- This results in a stronger systolic pulse
- Gallop rhythm
- Wheeze (cardiac asthma)
- Fine crackles throughout lung
• Right Heart Failure
- Raised JVP
- Hepatomegaly
- Ascites
- Ankle/sacral pitting oedema
- Signs of functional tricuspid regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Investigations for cardiac failure

A
• Bloods
-FBC 
-U&amp;E 
-LFTs 
-CRP 
-Glucose 
-Lipids 
-TFTs
• In ACUTE Left Ventricular Failure
- ABG 
-Troponin 
-BNP
• Raised plasma BNP suggests diagnosis of cardiac failure
• Low plasma BNP rules out cardiac failure (90% sensitivity)
• CXR
- Alveolar shadowing 
-Kerley B lines 
-Cardiomegaly
-Upper Lobe Diversion 
-Pleural Effusion
• ECG
- may be normal
- may show ischaemic changes (pathological q waves, t wave inversion) 
- may show arrhythmia or left ventricular hypertrophy 
• Echocardiogram
- Assess ventricular contraction
- Systolic dysfunction = LV ejection fraction < 40%
- Diastolic dysfunction = decreased compliance of the myocardium leads to restrictive filling defect
• Swan-Ganz Catheter
- Allows measurement of right atrial, right ventricular, pulmonary artery, pulmonary wedge and left ventricular end-diastolic pressures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Management plan for cardiac failure (Acute Left Ventricular Failure & Chronic Left Ventricular Failure)

A

**Acute Left Ventricular Failure
- Treating Cardiogenic Shock:
• This is severe cardiac failure with low blood pressure
• Requires the use of inotropes (e.g. dobutamine)
• Managed in ITU
-Treating Pulmonary Oedema:
• Sit the patient up
• 60-100% Oxygen (and consider CPAP)
• Diamorphine (venodilator + anxiolytic)
• GTN infusion (venodilator –> reduced preload)
• IV furosemide (venodilator and later diuretic effect)
• Monitor:
BP
Respiratory rate
Oxygen saturation
Urine output
ECG
• TREAT THE CAUSE! (e.g. MI, arrhythmia)

** Chronic Left Ventricular Failure
-TREAT THE CAUSE (e.g. hypertension)
-TREAT EXACERBATING FACTORS (e.g. anaemia)
-ACE Inhibitors
• Inhibits renin-angiotensin system and inhibits adverse cardiac remodelling
• They slow down the progression of heart failure and improve survival
-Beta-Blockers
• Blocks the effects of a chronically activated sympathetic system
• Slows progression of heart failure and improves survival
• The benefits of ACE inhibitors and beta-blockers are additive
-Loop Diuretics
• Alongside dietary salt restriction, can correct fluid overload
-Aldosterone Antagonists
• Improves survival in patients with NYHA class III/IV symptoms on standard therapy
• Monitor K+ (as these drugs may cause hyperkalaemia)
- Angiotensin Receptor Blockers
• May be added in patients with persistent symptoms despite the use of ACE inhibitors and beta-blockers
• Monitor K+ (as these drugs may cause hyperkalaemia)
-Hydralazine and a Nitrate
• May be added in patients (particularly Afro-Caribbeans) with persistent symptoms despite the use of ACE inhibitors and beta-blockers
Digoxin
• Positive inotrope
• Reduces hospitalisation but does NOT improve survival N-3 Polyunsaturated Fatty Acids
• Provide a small beneficial advantage in terms of survival Cardiac Resynchronisation Therapy
• Biventricular pacing improves symptoms and survival in patients with a left ventricular ejection fraction < 35%, cardiac dyssynchrony (QRS > 120 msec) and moderate-severe symptoms
• These patients are also candidates for implantable cardioverter defibrillator (ICD)
• They may receive a combined device
CAUTION: avoid drugs that could adversely affect a patient with heart failure due to systolic dysfunction (e.g. NSAIDs, non-dihydropyridine CCBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Identify possible complications of cardiac failure

A
  • Respiratory failure
  • Cardiogenic Shock
  • Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Summarise the prognosis for a patient with cardiac failure

A
  • 50% with cardiac failure die within 2 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Define Cardiomyopathy

A

Primary disease of the myocardium. Cardiomyopathy may be:

  • dilated
  • hypertrophic
  • restrictive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Aetiology/ Risk factors of cardiomyopathy

A
•  The majority are IDIOPATHIC 
•  Dilated Cardiomyopathy 
o  PostMviral myocarditis  
o  Alcohol 
o  Drugs (e.g. doxorubicin, cocaine)  o  Familial 
o  Thyrotoxicosis  
o  Haemochromatosis  
o  Peripartum  
 •  Hypertrophic Cardiomyopathy 
o  Up to 50% are genetic 
•  Restrictive Cardiomyopathy 
o  Amyloidosis  
o  Sarcoidosis  
o  Haemochromatosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Summarise the epidemiology of cardiomyopathy

A
  • prevalence of dilated and hypertrophic cardiomyopathy is 0.05-0.20%
  • restricted is even rarer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Presenting symptoms of cardiomyopathy

A
•  Dilated 
o  Symptoms of heart failure 
o  Arrhythmias  
o  Thromboembolism 
o  Family history of sudden death  
•  Hypertrophic 
o  Usually NO SYMPTOMS 
o  Syncope  
o  Angina  
o  Arrhythmias  
o  Family history of sudden death 
•  Restrictive 
o  Dyspnoea 
o  Fatigue  
o  Arrhythmias  
o  Ankle or abdominal swelling  
o  Family history of sudden death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Signs of cardiomyopathy on physical examination

A
•  Dilated 
o  Raised JVP  
o  Displaced apex beat  
o  Functional mitral and tricuspid regurgitations   
o  Third heart sound  
•  Hypertrophic 
o  Jerky carotid pulse  
o  Double apex beat  
o  Ejection systolic murmur  
•  Restrictive 
o  Raised JVP  
•  Kussmaul Sign M paradoxical rise in JVP on inspiration due to restricted  filling of the ventricles  
o  Palpable apex beat   o  Third heart sound   o  Ascites  
o  Ankle oedema  
o  Hepatomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Investigations for cardiomyopathy

A

• CXR
o May show cardiomegaly
o May show signs of heart failure

•  ECG 
o  All Types 
•  Non-specific ST changes   
•  Conduction defects  
•  Arrhythmias  
o  Hypertrophic 
•  LeftMaxis deviation 
•  Signs of left ventricular hypertrophy  
•  Q waves in inferior and lateral leads  
o  Restrictive 
•  Low voltage complexes  

• Echocardiography
o Dilated
• Dilated ventricles with global hypokinesia
o Hypertrophic
• Ventricular hypertrophy (asymmetrical septal hypertrophy)
o Restrictive
• Non-dilated non-hypertrophied ventricles
• Atrial enlargement
• Preserved systolic function
• Diastolic dysfunction
• Granular or sparkling appearance of myocardium in amyloidosis
• Cardiac Catheterisation
• Endomyocardial Biopsy
• Pedigree or Genetic Analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Define Constrictive Pericarditis

A

Chronic inflammation of the pericardium with thickening and scarring. It limits the ability of the heart to function normally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Explain the aetiology/ risk factors of constrictive pericarditis

A
•  NOTE: it is often underdiagnosed because it is difficult to distinguish it from restrictive  cardiomyopathy and other causes of right heart failure  
•  Can occur after any pericardial disease process  
•  More common causes of pericarditis:  
o  Idiopathic 
o  Virus 
o  TB 
o  Mediastinal irradiation  
o  Post-surgical  
o  Connective tissue disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Summarise the epidemiology of constrictive pericarditis

A
  • RARE
  • Documented in all ages
  • 9% of patients with acute pericarditis will develop constrictive pericarditis • TB has the HIGHEST TOTAL INCIDENCE out of all causes
  • More common in MALES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Recognise the presenting symptoms and signs of constrictive pericarditis

A

• GradualMonset of symptoms
• EARLY - symptoms and signs may be very subtle • ADVANCED - jaundice, cachexia, muscle wasting • Right Heart Failure Signs
o Dyspnoea
o Peripheral oedema
o Raised JVP
o Kussmaul’s sign (paradoxical rise in JVP on inspiration) o Pulsatile hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Investigations for constrictive pericarditis

A

• CXR - may show calcification of the pericardium
• Echocardiogram - usually diagnostic and helps distinguish from restrictive
cardiomyopathy
• MRI - allows assessment of thickness of pericardium
• CT - same role as MRI
• Pericardial biopsy - may be indicated (especially if suspected infective cause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Define DVT

A

Formation of a thrombus within the deep veins (most commonly in the calf or thigh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Explain the aetiology/risk factors of DVT

A

• Deep veins in the legs are more prone to blood stasis, hence clots are more likely to
form (look up Virchow’s triad) • Risk Factors
o OCP
o PostMsurgery
o Prolonged immobility
o Obesity
o Pregnancy
o Dehydration
o Smoking
o Polycythaemia
o Thrombophilia (e.g. protein C deficiency) o Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Summarise the epidemiology of DVT

A
  • Very common

- Especially in hospitalised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Recognise the signs of DVT on physical examination

A

• Examination of the Leg
o Local erythema, warmth and swelling o Measure the leg circumference
o Varicosities (swollen/tortuous vessels) o Skin colour changes
o NOTE: Homan’s Sign M forced passive dorsiflexion of the ankle causes deep calf pain

• Risk is stratified using the WELLS CRITERIA (NOTE: this is different from the PE Wells criteria)
o Score 2 or more = high risk
• Examine for PE
o Check respiratory rate, pulse oximetry and pulse rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Identify appropriate investigations for DVT

A

• Doppler Ultrasound - GOLD STANDARD

• Impedance Plethysmography - changes in blood volume results in changes of
electrical resistance
• Bloods
o D-dimer: can be used as a negative predictor
o Thrombophilia screen if indicated
• If PE suspected
o ECG o CXR o ABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Management plan for DVT

A

• ANTICOAGULATION
o Heparin whilst waiting for warfarin to increase INR to the target range of 2-3
o DVTs that do NOT extend above the knee may be observed and anticoagulated
for 3 months
o DVTs extending beyond the knee require anticoagulation for 6 months
o Recurrent DVTs require long-term warfarin
• IVC Filter
o May be used if anticoagulation is contraindicated and there is a risk of
embolisation
• Prevention
o Graduated compression stockings
o Mobilisation
o Prophylactic heparin (if high risk e.g. hospitalised patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Identify possible complications of DVT

A
  • PE
  • Venous infarction (phlegmasia cerulea dolens) • Thrombophlebitis (results from recurrent DVT)
  • Chronic venous insufficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Summarise the prognosis for patients with DVT

A
  • Depends on extent of DVT
  • Below-knee DVTs have a GOOD prognosis
  • Proximal DVTs have a greater risk of embolisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Define Gangrene and Necrotising Fasciitis

A

Gangrene: tissue necrosis, either wet with superimposed infection, dry or gas gangrene

Necrotising Fasciitis: a life-threatening infection that spreads rapidly across fascial planes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Explain the aetiology/ risk factors of necrotising fasciitis

A
•  Gangrene 
o  Tissue ischaemia and infarction  
o  Physical trauma  
o  Thermal injury  
o  Gas gangrene is caused by Clostridia perfringens 

• Necrotising Fasciitis
o Usually polymicrobial involving streptococci, staphylococci, bacterioides and
coliforms

 •  Risk Factors 
o  Diabetes  
o  Peripheral vascular disease   o  Leg ulcers  
o  Malignancy  
o  Immunosuppression  
o  Steroid use  
o  Puncture/surgical wounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Summarise the epidemiology of gangrene and necrotising fasciitis

A
  • Gangrene - relatively COMMON

* Necrotising fasciitis and gas gangrene - RARE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Recognise the presenting symptoms of gangrene and necrotising fasciitis

A

–• Gangrene
o Pain
o Discolouration of affected area
o Often affects extremities or areas subject to high
pressure
–• Necrotising Fasciitis
o Pain
–• Often seems SEVERE and out of proportion to the apparent physical signs
o Predisposing event (e.g. trauma, ulcer, surgery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Recognise the signs of gangrene and necrotising fasciitis on examination

A

• Gangrene
o Painful area = erythematous region around gangrenous tissue
o Gangrenous tissue = BLACK because of haemoglobin break down products
o Wet Gangrene M tissue becomes boggy with associated pus and a strong odour
caused by the activity of anaerobes
o Gas Gangrene M spreading infection and destruction of tissues causes overlying
oedema, discolouration and crepitus (due to gas formation by the infection)

• Necrotising Fasciitis
o Area of erythema and oedema
o Haemorrhagic blisters may be present
o Signs of systemic inflammatory response and sepsis (high/low temperature,
tachypnoea, hypotension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Investigations for gangrene and necrotising fasciitis

A
  • Bloods - FBC, U&Es, glucose, CRP and blood culture
  • Wound Swab, Pus/Fluid Aspirate - MC&S
  • X-ray of affected area - may show gas produced in gas gangrene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Define Heart Block (1st, 2nd, 3rd degree)

A

• 1st Degree AV Block: prolonged conduction through the AV node • 2nd Degree AV Block:
o Mobitz Type I (Wenckebach): progressive prolongation of AV node conduction culminating in one atrial impulse failing to be conducted through the AV node. The cycle ten begins again.
o Mobitz Type II: intermittent or regular failure of conduction through the AV node. Also defined by the number of normal conductions per failed or abnormal one (e.g. 2:1 or 3:1)
• 3rd Degree (Complete) AV Block: no relationship between atrial and ventricular contraction. Failure of conduction through the AV node leads to ventricular contraction generated by a focus of depolarisation within the ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Epidemiology of heart block

A

250,000 pacemakers are implanted every year and they are mostly for heart block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Aetiology/ Risk Factors for heart block

A
  • MI or ischaemic heart disease (MOST COMMON)
  • Infection (e.g. rheumatic fever, infective endocarditis) • Drugs (e.g. digoxin)
  • Metabolic (e.g. hyperkalaemia)
  • Infiltration of conducting system (e.g. sarcoidosis)
  • Degeneration of the conducting system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Presenting symptoms of heart block

A

• 1st Degree - asymptomatic
• 2nd Degree - usually asymptomatic
• Mobitz Type II and 3rd Degree - may cause Stokes-Adams Attacks (syncope caused by ventricular asystole)
o May also cause dizziness, palpitations, chest pain and heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Recognise signs of heart block on physical examination

A

• Often NORMAL
• Check for signs of a potential cause of heart block
• Complete Heart Block
o Slow large volume pulse
o JVP may show cannon a waves
• Cannon A Waves: waves seen occasionally in the jugular vein of humans with certain cardiac arrhythmias. This occurs when the atria and ventricles contract simultaneously
• Mobitz Type II and 3rd Degree Heart Block
o Signs of reduced cardiac output (e.g. hypotension, heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Identify appropriate investigations for heart block

A

• ECG J GOLD STANDARD
o First Degree- fixed prolonged PR interval (> 0.2 s)
o Mobitz Type I (Wenckebach) M progressively prolonged PR interval, culminating
in a P wave that is NOT followed by a QRS complex. The pattern then begins again. ‘Going, going, gone’.
o Mobitz Type II M intermittently a P wave is NOT followed by a QRS. There may be
a regular pattern of P waves not followed by QRS (e.g. 2:1 or 3:1)
o Complete Heart Block M no relationship between P waves and QRS complexes. If
QRS is initiated in the:
• Bundle of His M narrow complex
• More distally M wide complex and slow rate (~ 30 bpm)
• CXR
o Cardiac enlargement
o Pulmonary oedema
• Bloods
o TFTs
o Digoxin level
o Cardiac enzymes
o Troponin
• Echocardiogram
o Wall motion abnormalities o Aortic valve disease
o Vegetations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Generate a management plan for heart block

A

• Chronic Block
o Permanent pacemaker is recommended in:
• Complete heart block
• Advanced Mobitz Type II
• Symptomatic Mobitz Type I
• Acute Block
o If associated with clinical deterioration use IV atropine o Consider temporary (external) pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Identify the possible complications of heart block

A
  • Asystole
  • Cardiac arrest
  • Heart failure
  • Complications of any pacemaker inserted
89
Q

Summarise the prognosis for patients with heart block

A

• Mobitz Type II and 3rd degree block usually indicate serious underlying cardiac disease

90
Q

Define Hypertension

A

• Systolic > 140 mm Hg and/or diastolic > 90 mm Hg measured on three separate
occasions.
• Malignant Hypertension: BP > 200/130 mm Hg

91
Q

Summarise the epidemiology of hypertension

A
  • VERY COMMON

* 10-20% of adults in the Western world

92
Q

Aetiology/ Risk Factors of hypertension

A
•  Primary 
o  Essential or idiopathic hypertension  
o  Responsible for > 90% of cases  
•  Secondary 
o  Renal 
•  Renal artery stenosis  
•  Chronic glomerulonephritis   •  Chronic pyelonephritis  
•  Polycystic kidney disease  
•  Chronic renal failure 
o  Endocrine 
•  Diabetes mellitus  
•  Hyperthyroidism 
•  Cushing's syndrome  
•  Conn's syndrome  
•  Hyperparathyroidism 
•  Phaeochromocytoma 
•  Congenital adrenal hyperplasia   •  Acromegaly 
o  Cardiovascular 
•  Coarctation of the aorta  
•  Increased intravascular volume  
o  Drugs 
•  Sympathomimetics  
 •  Corticosteroids 
•  COCP 
o  Pregnancy 
•  Pre-eclampsia
93
Q

Presenting symptoms of hypertension

A
•  Often ASYMPTOMATIC 
•  Symptoms of complications 
•  Symptoms of the cause 
•  Accelerated or Malignant Hypertension 
o  Scotomas (visual field loss)   o  Blurred vision  
o  Headache  
o  Seizures  
o  Nausea and vomiting  
o  Acute heart failure
94
Q

Signs of hypertension on physical examination

A

• Blood pressure should be measured on 2-3 different occasions before diagnosing
hypertension
• The lowest reading should be recorded
• Examination may reveal information about causes:
o Radiofemoral delay = coarctation of the aorta distal to the left subclavian artery
o Renal artery bruit = renal artery stenosis
o Fundoscopy to detect hypertensive retinopathy
Keith-Wagner Classification of Hypertensive Retinopathy i. Silver wiring
ii. As above + arteriovenous nipping
iii. As above + flame haemorrhages + cotton wood exudates iv. As above + papilloedema

95
Q

Investigations for hypertension

A
•  Bloods: 
o  U&amp;Es 
o  Glucose  
o  Lipids  
•  Urine Dipstick 
o  Blood and protein (e.g. if glomerulonephritis)  
•  ECG 
o  May show signs of left ventricular hypertrophy or ischaemia  
•  Ambulatory blood pressure monitoring 
o  Excludes white coat hypertension  
•  Other investigations may be performed if a secondary cause of the hypertension is 
suspected (e.g. renal angiogram)
96
Q

management plan for hypertension

A

• Conservative
o Stop smoking
o Lose weight
o Reduce alcohol intake
o Reduce dietary sodium
• Investigate for secondary causes (mainly in young patients)
• Medical - treatment recommended if systolic > 160 mmHg and/or diastolic > 100 mmHg, or if evidence of end-organ damage. Multiple drug therapies often needed.
o ACE Inhibitors or Angiotensin Receptor Blockers - first line if:
• < 55 yrs
• Diabetic
• Heart failure
• Left ventricular dysfunction
o CCBs - first line if:
• > 55 yrs
• Black
• NOTE: thiazide diuretics can be used if CCBs are not tolerated
o Beta-Blockers
• Not preferred initial therapy
• May be considered in younger patients
•CAUTION: combining with thiazide diuretic may increase risk of developing diabetes
•May increase risk of heart failure
o Alpha-Blockers
• 4th line
• May be used in patients with prostate disease
• Target BP
o Non-Diabetic: < 140/90 mm Hg
o Diabetes without proteinuria: < 130/80 mm Hg o Diabetes WITH proteinuria: < 125/75 mm Hg
• Severe Hypertension Management (Diastolic > 140 mm Hg)
o Atenolol
o Nifedipine
• Acute Malignant Hypertension Management:
o IV beta-blocker (e.g. esmolol)
o Labetolol
o Hydralazine sodium nitroprusside
o CAUTION: avoid rapid lowering of blood pressure because it can cause cerebral
infarction
• This is because the autoregulatory mechanisms within the brain for
regulating blood flow will cause vasoconstriction of the vessels in the brain
when blood pressure is very high
• Lowering the blood pressure too rapidly would mean that the
autoregulatory mechanisms do not adapt to the drop in blood pressure and
so the vessels remain constricted
• A rapid drop in blood pressure with constricted vessels will cause an
infarction

97
Q

Identify possible complications of hypertension

A
  • Heart failure
  • Coronary artery disease
  • Cerebrovascular accidents
  • Peripheral vascular disease
  • Emboli
  • Hypertensive retinopathy
  • Renal failure
  • Hypertensive encephalopathy
  • Posterior reversible encephalopathy syndrome (PRES)
  • Malignant hypertension
98
Q

Summarise the prognosis for patients with hypertension

A
  • Good prognosis if well controlled
  • Uncontrolled hypertension is associated with increased mortality
  • Treatment reduces incidence of renal damage, stroke and heart failure
99
Q

Infective Endocarditis

A

Infection of intracardiac endocardial structures (mainly heart valves)

100
Q

Aetiology/ Risk Factors of Infective Endocarditis

A

• Most common organisms causing infective endocarditis:
o Streptococci (40%) - mainly a-haemolytic S. viridans and S. bovis
o Staphylococci (35%) - S. aureus and S. epidermidis
o Enterococci (20%) - usually E. faecalis
o Other organisms:
• Haemophilus
• Actinobacillus
• Cardiobacterium
• Coxiella burnetii
• Histoplasma (fungal)

• Pathophysiology
o Vegetations form when organisms deposit on the heart valves during a period of
bacteraemia
o The vegetations are made up of platelets, fibrin and infective organisms
o They destroy valve leaflets, invade the myocardium or aortic wall leading to
abscess cavities
o Activation of the immune system can lead to the formation of immune
complexes –> vasculitis, glomerulonephritis, arthritis

• Risk Factors
o Abnormal valves (e.g. congenital, calcification, rheumatic heart disease)
o Prosthetic heart valves
o Turbulent blood flow (e.g. patent ductus arteriosus)
o Recent dental work/poor dental hygiene (source of S. viridans)

101
Q

Summarise the epidemiology of infective endocarditis

A

Uk incidence: 16-22/1 million per year

102
Q

Recognise the presenting symptoms of infective endocarditis

A
•  Fever with sweats/chills/rigors  
o  NOTE: this might be relapsing and remitting  
•  Malaise  
•  Arthralgia  
•  Myalgia  
•  Confusion  
•  Skin lesions  
•  Ask about recent dental surgery or IV drug use
103
Q

Recognise the signs of infective endocarditis on physical examination

A

• Pyrexia
• Tachycardia
• Signs of anaemia
• Clubbing
• New regurgitant murmur or muffled heart sounds
• Frequency of heart murmurs:
o Mitral > Aortic > Tricuspid > Pulmonary
• Splenomegaly
• Vasculitic Lesions
o Roth spots on retina
o Petechiae on pharyngeal and conjunctival mucosa
o Janeway lesions (painless macules on the palms which blanch on pressure) o Osler’s nodes (tender nodules on finger/toe pads)
o Splinter haemorrhages

104
Q

Appropriate investigations for infective endocarditis

A

• Bloods
o FBC - high neutrophils, normocytic anaemia
o High ESR/CRP
o U&Es
o NOTE: a lot of patients with infective endocarditis tend to be rheumatoid factor
positive
• Urinalysis
o Microscopic haematuria
o Proteinuria
• Blood Culture
o Do microscopy and sensitivities as well
• Echocardiography
o Transthoracic or transoesophageal (produces better image)
• Duke’s Classification - a method of diagnosing infective endocarditis based on the
findings of the investigations and the symptoms/signs

105
Q

Management plan for infective endocarditis

A
•  Antibiotics for 4-6 weeks  
•  On clinical suspicion = EMPIRICAL TREATMENT 
o  Benzylpenicillin 
o  Gentamicin 
•  Streptococci - continue the same as above  
•  Staphylococci  
o  Flucloxacillin/vancomycin 
o  Gentamicin 
•  Enterococci 
o  Ampicillin 
o  Gentamicin 
•  Culture Negative 
o  Vancomycin 
o  Gentamicin  
•  SURGERY - urgent valve replacement may be needed if there is a poor response to 
antibiotics
106
Q

Possible complications of infective endocarditis

A
  • Valve incompetence
  • Intracardiac fistulae or abscesses
  • Aneurysm
  • Heart failure
  • Renal failure
  • Glomerulonephritis
  • Arterial emboli from the vegetations shooting to the brain, kidneys, lungs and spleen
107
Q

Summarise the prognosis for patients with infective endocarditis

A
  • Fatal if untreated

- 15-30% mortality even with treatment

108
Q

Define Ischaemic Heart Disease

A

Characterised by decreased blood supply to the heart muscle resulting in chest pain (angina pectoris). May present as stable angina or acute coronary syndrome

ACS can be further subdivided into:

  • Unstable angine: chest pain at rest due to ischaemia but without cardiac injury
  • NSTEMI
  • STEMI

Note: MI= cardiac muscle necrosis resulting from ischaemia

109
Q

Epidemiology of ischaemic heart disease

A
  • COMMON
  • Prevalence: > 2 %
  • More common in males
  • Annual incidence of MI in the UK ~ 5/1000
110
Q

Aetiology/ Risk Factors of ischaemic heart disease

A

• Angina pectoris occurs when myocardial oxygen demand exceeds oxygen supply
• This is usually due to atherosclerosis
• Rarer causes of angina pectoris include coronary artery spasm (e.g. induced by
cocaine), arteritis and emboli
• Atherosclerosis pathophysiology
o Endothelial injury leads to migration of monocytes into the subendothelial space
o These monocytes differentiate into macrophages
o Macrophages accumulate LDL lipids and become foam cells
o These foam cells release growth factors that stimulate smooth muscle
proliferation, production of collagen and proteoglycans o This leads to the formation of an atherosclerotic plaque
• Risk Factors
o Male
o Diabetes mellitus
o Family history
o Hypertension
o Hyperlipidaemia
o Smoking

111
Q

Recognise the presenting symptoms of ischaemic heart disease

A

• ACS
o Acute-onset chest pain
o Central, heavy, tight, crushing pain
o Radiates to the arms, neck, jaw or epigastrium
o Occurs at rest
o More severe and frequent pain that previously occurring stable angina
o Associated symptoms:
• Breathlessness
• Sweating
• Nausea and vomiting
• SILENT INFARCTS occur in the elderly and diabetics
• Stable Angina
o Chest pain brought on by exertion and relieved by rest

112
Q

Recognise the signs of ischaemic heart disease on physical examination

A
•  Stable Angina 
o  Check for signs of risk factors   
•  ACS 
o  There may be NO CLINICAL SIGNS  
o  Pale  
o  Sweating  
o  Restless 
o  Low-grade pyrexia  
o  Check both radial pulses to rule out aortic dissection 
o  Arrhythmias  
o  Disturbances of BP  
o  New heart murmurs  
o  Signs of complications (e.g. acute heart failure, cardiogenic shock)
113
Q

Identify investigations for ischaemic heart disease

A

• Bloods
o FBC
o U&Es
o CRP
o Glucose
o Lipid profile
o Cardiac enzymes (troponins and CK-MB)
o Amylase (pancreatitis could mimic MI)
o TFTs
o AST and LDH (raised 24 and 48 hours post-MI, respectively)
• ECG
o Unstable Angina or NSTEMI:
• May show ST depression or T wave inversion
o STEMI:
• Hyperacute T waves
• ST elevation (> 1 mm in limb leads, > 2 mm in chest leads)
• New-onset LBBB
• Later changes:
! T wave inversion
! Pathological Q waves
o Relationship between ECG leads and the side of the heart
• Inferior: II, III, aVF
• Anterior: V1MV5/6
• Lateral: I, aVL, V5/6
• Posterior: Tall R wave and ST depression in V1-3
• CXR
o Check for signs of heart failure
• Exercise ECG
o Indications
• Patients with troponin-negative ACS or stable angina with a high pretest probability of coronary heart disease
• Pretest probability is based on characteristics of chest pain, cardiac risk factors, age and gender
• NOTE: digoxin is associated with giving a false-positive result o Results:
• Positive Test: > 1 mm horizontal or downsloping ST depression measured at 80 ms after the end of the QRS complex
• Failed Test: failure to achieve at least 85% of the predicted maximal heart rate (220-age) and otherwise negative findings (no chest pain or ECG changes)
! NOTE: beta-blockers reduce heart rate and so should be stopped before the test
• Resting ECG Abnormalities: e.g. pre-excitation syndrome, > 1 mm ST depression, LBBB or pacemaker ventricular rhythm
• Radionuclide Myocardial Perfusion Imaging (rMPI)
o Uses Technetium-99m sestamibi or tetrofosmin
o Can be performed under stress or at rest
o Stress testing shows low uptake in ischaemic myocardium
• Echocardiogram
o Measures left ventricular ejection fraction
o Exercise or dobutamine stress echo may detect regional wall motion
abnormalities
• Pharmacological Stress Testing
o This is used in patients who are unable to exercise
o Pharmacological agents can be used to induce a tachycardia, such as:
• Dipyridamole
• Adenosine
• Dobutamine
o These agents are used in conjunction with various imaging modalities (e.g. rMPI, echocardiography) to detect ischaemic myocardium
o NOTE: Dypiridamole and adenosine are contraindicated in AV block and reactive airway disease
• Cardiac Catheterisation/Angiography
o Performed if ACS with positive troponin or if high risk on stress testing
• Coronary Calcium Scoring
o Uses specialised CT scan
o May be useful in outpatients with atypical chest pain or in acute chest pain that
isn’t clearly due to ischaemia

114
Q

Management for stable angina

A

o Minimise cardiac risk factors (e.g. blood pressure, hyperlipidaemia, diabetes)
• All patients should receive aspirin 75 mg/day unless contraindicated
o Immediate symptom relief (e.g. GTN spray)
o LongJterm management
• Beta-blockers
! Contraindicated in:
• Acute heart failure
• Cardiogenic shock
• Bradycardia
• Heart block
• Asthma
• Calcium channel blockers
• Nitrates
o Percutaneous coronary intervention (PCI)
• Performed in patients with stable angina despite maximal tolerable medical therapy
o Coronary artery bypass graft (CABG)
• Occurs in more severe cases (e.g. three-vessel disease)

115
Q

Management plan for unstable angina/ NSTEMI

A

o Admit to coronary care unit
o Oxygen, IV access, monitor vital signs and serial ECG
o GTN
o Morphine
o Metoclopramide (to counteract the nausea caused by morphine)
o Aspirin (300 mg initially, followed by 75 mg indefinitely)
o Clopidogrel (300 mg initially, followed by 75 mg for at least 1 year if troponin
positive or high risk)
o LMWH (e.g. enoxaparin)
o Beta-blocker (e.g. metoprolol)
o Glucose-insulin infusion if blood glucose > 11 mmol/L
o GlpIIb/IIIa inhibitors may also be considered (e.g. tirofiban) in patients:
• Undergoing PCI
• At high risk of further cardiac events
o If little improvement, consider urgent angiography with/without
revascularisation
o NOTE: the acute management of ACS can be remembered using the mnemonic
MONABASH
• Morphine
• Oxygen
• Nitrates
• Anticoagulants (aspirin + clopidogrel)
• BetaMblockers
• ACE inhibitors
• Statins
• Heparin

116
Q

Management plan for STEMI

A

o Same as UAP/NSTEMI management except:
• Clopidogrel
! 600 mg if patient is going to PCI
! 300 mg if undergoing thrombolysis and < 75 yrs
! 75 mg if undergoing thrombolysis and > 75 yrs
! MAINTENANCE: 75 mg daily for at least 1 year
• If undergoing primary PCI:
! IV heparin (plus GlpIIb/IIIa inhibitor)
! Bivalirudin (antithrombin) o Primary PCI
• Goal < 90 min if available o Thrombolysis
• Uses fibrinolytics such as streptokinase and tissue plasminogen activator (e.g. alteplase)
• Only considered if within 12 hours of chest pain with ECG changes and not contraindicated
• Rescue PCI may be performed if continued chest pain or ST elevation after thrombolysis
o Secondary Prevention
• Dual antiplatelet therapy (aspirin + clopidogrel) • BetaMblockers
• ACE inhibitors
• Statins
• Control risk factors
o Advice
• No driving for 1 month following MI
o CABG
• Considered in patients with left main stem or threeMvessel disease

117
Q

Identify the possible complications of ischaemic heart disease

A
•  Increased risk of MI and other vascular disease (e.g. stroke, PVD) 
•  Cardiac injury from an MI can lead to heart failure and arrhythmias  
•  Early Complications (within 24-72 hrs) 
o  Death  
o  Cardiogenic shock  
o  Heart failure  
o  Ventricular arrythmias  
 o  Heart block 
o  Pericarditis  
o  Myocardial rupture  
o  Thromboembolism 
•  Late Complications 
o  Ventricular wall rupture   
o  Valvular regurgitation  
o  Ventricular aneurysms   
o  Tamponade  
o  Dressler's syndrome  
o  Thromboembolism  
•  MNEMONIC for Complications of MI  
o  Death 
o  Arrhythmias  
o  Rupture 
o  Tamponade 
 o  Heart failure  
o  Valve disease  
o  Aneurysm 
o  Dressler's syndrome  
o  Embolism
118
Q

Summarise the prognosis for patients with ischaemic heart disease

A

• TIMI score (0-7) can be used for risk stratification
o NOTE: TIMI = thrombolysis in myocardial infarction
o High scores are associated with high risk of cardiac events within 30 days of MI
• Killip Classification of acute MI can also be used: o Class I: no evidence of heart failure
o Class II: mild to moderate heart failure
o Class III: over pulmonary oedema
o Class IV: cardiogenic shock

119
Q

Define Mitral Regurgitation

A

Retrogade flow of blood from left ventricle to left atrium during systole

120
Q

Epidemiology of mitral regurgitation

A
  • Affect ~5% of adults

* Mitral valve prolapse is common in young females

121
Q

Aetiology/ Risk factors of mitral regurgitation

A

• Broadly speaking, it is caused by mitral valve damage or dysfunction, which, in turn could be caused by any of the following:
o Rheumatic heart disease (MOST COMMON)
o Infective endocarditis
o Mitral valve prolapse
o Papillary muscle rupture or dysfunction (secondary to IHD or cardiomyopathy)
o Chordal rupture and floppy mitral valve associated with connective tissue disease
(e.g. Ehlers-Danlos syndrome, Marfan’s syndrome)

122
Q

Presenting symptoms of mitral regurgitation

A

• Acute MR - may present with symptoms of left ventricular failure
• Chronic MR - may be asymptomatic or present with:
o Exertional dyspnoea
o Palpitations if in AF
o Fatigue
• Mitral Valve Prolapse -asymptomatic or atypical chest pain or palpitations

123
Q

Recognise the signs of mitral regurgitation on physical examination

A

• Pulse may be irregularly irregular (if in AF)
• Laterally displaced apex beat with thrusting (due to left ventricular dilation)
• Pansystolic murmur
o Loudest at apex beat
o Radiating to the axilla
o Soft S1
o S3 may be heard due to rapid ventricular filling in early diastole
• Signs of left ventricular failure in acute mitral regurgitation
• Mitral Valve Prolapse
o Mid-systolic click
o Late systolic murmur
o The click moves towards S1 when standing and away when lying down

124
Q

Investigations for mitral regurgitation

A

• ECG
o NORMAL
o May show AF or p mitrale (indicates left atrial hypertrophy)

• CXR
o ACUTE mitral regurgitation may produce signs of left ventricular failure o CHRONIC mitral regurgitation shows:
• Left atrial enlargement
• Cardiomegaly (due to LV dilation)
• Mitral valve calcification (if rheumatic heart disease is the cause)
• Echocardiography
o Performed every 6-12 months in moderate-severe MR
o Allows assessment of LV ejection fraction and end-systolic dimension

125
Q

Define mitral stenosis

A

Mitral valve narrowing causing obstruction to blood flow from the left atrium to the left ventricle

126
Q

Epidemiology of mitral stenosis

A

Declining incidence because rheumatic fever is becoming more and more rare

127
Q

Aetiology/ Risk factors for mitral stenosis

A
•  MAIN CAUSE: Rheumatic Heart Disease (90% of cases)   •  Rare causes of mitral stenosis: 
o  Congenital mitral stenosis   
o  SLE  
o  Rheumatoid arthritis 
o  Endocarditis  
o  Atrial myxoma
128
Q

Presenting symptoms of mitral stenosis

A
•  May be ASYMPTOMATIC 
•  Fatigue  
•  Shortness of breath on exertion   
•  Orthopnoea 
•  Palpitations (related to AF)  
•  Rare symptoms: 
o  Cough 
o  Haemoptysis  
o  Hoarseness caused by compression of left recurrent laryngeal nerve by an 
enlarged left atrium
129
Q

Recognise the signs of mitral stenosis on physical examination

A

• Peripheral cyanosis
• Malar flush
• Irregularly irregular pulse (if in AF)
• Apex beat undisplaced and tapping
• Parasternal heave (due to right ventricular hypertrophy
secondary to pulmonary hypertension)
• Loud S1 with opening snap
• Mid-diastolic murmur
• Evidence of pulmonary oedema on lung auscultation (if decompensated)

130
Q

Identify appropriate investigations for mitral stenosis

A

• ECG
o May be NORMAL
o May see p mitrale (broad bifid p wave caused by left atrial hypertrophy)
o May see AF
o Evidence of right ventricular hypertrophy may be seen if there is severe
pulmonary hypertension
• CXR
o Left atrial enlargement
o Cardiac enlargement
o Pulmonary congestion
o Mitral valve calcification (occurs in rheumatic
cases)
• Echocardiography
o Assesses functional and structural impairments
o Transoesophageal echocardiogram (TOE) gives a better view
• Cardiac Catheterisation
o Measures severity of heart failure

131
Q

Define Myocarditis

A

Acute inflammation and necrosis of cardiac muscle

132
Q

Epidemiology of myocarditis

A
  • Incidence is difficult to measure accurately

* Coxsackie B virus is most common in Europe and USA • Chagas disease is most common in South America

133
Q

Aetiology/ Risk factors of myocarditis

A
•  Usually IDIOPATHIC  
•  Viruses 
o  Coxsackie B   
o  EBV 
o  CMV 
o  Adenovirus  
o  Influenza 
•  Bacteria 
o  Post-streptococcal 
 o  Tuberculosis  
o  Diphtheria 
•  Fungal 
o  Candidiasis 
•  Protozoal 
o  Trypanosomiasis (Chagas disease) 
•  Helminths 
o  Trichinosis 
•  NonJinfective 
o  Systemic: SLE, sarcoidosis, polymyositis  
o  Hypersensitivity myocarditis: sulphonamides  
•  Drugs 
o  Chemotherapy agents (e.g. doxorubicin, streptomycin) 
•  Others 
o  Cocaine, heavy metals, radiation
134
Q

Presenting symptoms of myocarditis

A
•  Prodromal flu-like illness with: 
 o  Fever  
o  Malaise  
o  Fatigue   
o  Lethargy 
•  Breathlessness (due to pericardial effusion/myocardial dysfunction)  
•  Palpitations  
•  Sharp chest pain (suggesting there is also pericarditis)
135
Q

Signs of myocarditis on examination

A
  • signs of pericarditis

- signs of complications

136
Q

Appropriate investigations for myocarditis

A
•  Bloods 
o  FBC - raised WCC if infective cause  
o  UandE
o  ESR/CRP-  raised  
o  Cardiac enzymes - may be raised  
o  Tests to identify cause (e.g. viral/bacterial serology, ANA, TFT) 
•  ECG 
o  Non-specific T wave and ST changes  
o  PERICARDITIS: widespread saddleMshaped ST elevation 
 •  CXR 
o  May be NORMAL 
o  May show cardiomegaly  
 •  Pericardial Fluid Drainage 
o  Measure glucose, protein, cytology, culture and sensitivity  
o  Helps identify causative organism  
•  Echocardiography 
o  Assesses systolic/diastolic function   
o  Wall motion abnormalities  
o  Pericardial effusions 
•  Myocardial Biopsy  
o  Rarely required
137
Q

Define Pericarditis

A

Inflammation of the pericardium

- may be acute, subacute or chronic

138
Q

Summarise the epidemiology of pericarditis

A
  • UNCOMMON
  • < 1/100 hospital admissions
  • More common in males
139
Q

Aetiology/ Risk Factors of pericarditis

A
•  IDIOPATHIC 
•  Infective 
Most common causative organisms: 
 o  Coxsackie B  
o  Echovirus 
o  Mumps  
o  Streptococci  
o  Fungi 
o  Staphylococci  
o  TB 
•  Connective tissue disease (e.g. sarcoidosis, SLE, scleroderma) 
•  PostMMI (within 24-72 hrs of MI - occurs in up to 20% of patients)  
•  Dressler's Syndrome - pericarditis occurring weeks/months after acute MI  
•  Malignancy - lung, breast, lymphoma, leukaemia, melanoma 
•  Radiotherapy 
•  Thoracic surgery 
•  Drugs (e.g. hydralazine, isoniazid)
140
Q

Presenting symptoms of pericarditis

A

• CHEST PAIN
o Sharp and central
o May radiate to the neck or shoulders
o Worse when coughing and deep inspiration (pleuritic pain)
o Relieved by sitting forward
• Dyspnoea
• Nausea

141
Q

Recognise signs of pericarditis on physical examination

A

• Fever
• Pericardial friction rub
o Heard best at lower left sternal edge, with patient leaning forward during expiration
• Heart sounds may be faint due to a pericardial effusion • Cardiac Tamponade signs
o Beck’s Triad (signs associated with acute cardiac tamponade)
• Raised JVP
• Low Blood Pressure
• Muffled Heart Sounds
o Tachycardia
o Pulsus paradoxus
(Definition: an abnormally large decrease in SBP (> 10 mm Hg drop) and
pulse wave amplitude during inspiration)
• Constrictive Pericarditis signs
o Kussmaul’s sign
o Pulsus paradoxus
o Hepatomegaly
o Ascites
o Oedema
o Pericardial knock (due to rapid ventricular filling)
o AF

142
Q

Identify appropriate investigations for pericarditis

A

• ECG - widespread saddle-shaped ST elevation
• Echocardiogram - assesses pericardial effusion and cardiac function
• Bloods
o FBC
o U&Es
o ESR/CRP
o Cardiac Enzymes (usually normal)
o Other investigations for cause: blood cultures,
ASO titres, ANA, rheumatoid factor
• CXR
o Usually normal
o May be globular if there is a pericardial effusion

143
Q

Management plan for pericarditis

A
•  Acute - cardiac tamponade is treated with emergency pericardiocentesis  
•  Medical  
o  Treat underlying cause  
o  NSAIDs for pain and fever relief   
•  Recurrent 
o  Low-dose steroids  
o  Immunosuppressants  
 o  Colchicine  
•  Surgical 
o  Pericardiectomy is performed in cases of constrictive pericarditis
144
Q

Complications of pericarditis

A
  • Pericardial effusion
  • Cardiac tamponade
  • Cardiac arrhythmias
145
Q

Prognosis for patients with pericarditis

A
  • Depends on the underlying cause
  • Viral cases have a GOOD prognosis
  • Malignant pericarditis has a POOR prognosis
146
Q

Define Peripheral Vascular Disease

A

Occurs due to atherosclerosis causing stenosis of arteries via a multifactorial process involving modifiable and non-modifiable risk factors

147
Q

Aetiology/ Risk Factors of peripheral vascular disease

A

• Occurs due to ATHEROSCLEROSIS in peripheral arteries
• Types of PVD include:
o Intermittent claudication - calf pain on exercise
o Critical limb ischaemia - pain at rest
• NOTE: this is the MOST SEVERE manifestation of peripheral vascular disease
o Acute limb ischaemia - a sudden decrease in arterial perfusion in a limb, due to thrombotic or embolic causes
o Arterial ulcers
o Gangrene
• Risk Factors (same as the risk factors for any other atherosclerotic disease)
o Smoking
o Diabetes
o Hypertension
o Hyperlipidaemia
o Physical inactivity
o Obesity

148
Q

Epidemiology of peripheral vascular disease

A
  • 55-70 yrs = 4-12% affected
  • 70+ yrs = 15-20% affected
  • More common in MALES
  • Incidence increases with AGE
149
Q

Presenting symptoms of peripheral vascular disease

A

• Intermittent claudication -cramping pain in the calf, thigh or buttock after walking for a given distance (claudication distance) and relieved by rest
o Calf claudication = femoral disease
o Buttock claudication = iliac disease
• Features of Critical Limb Ischaemia
o Ulcers
o Gangrene
o Rest pain
o Night pain (relieved by dangling leg over the edge of the bed)
• Leriche Syndrome (aortoiliac occlusive disease)
o Buttock claudication
o Impotence
o Absent/weak distal pulses

•  Fontaine Classification of Peripheral Vascular Disease  
o  Asymptomatic 
o  Intermittent Claudication  
 o  Rest pain  
o  Ulceration/gangrene
150
Q

Signs of peripheral vascular disease on physical examination

A
•  Acute Limb Ischaemia - 6 Ps 
 o  Pain 
o  Pale 
o  Pulseless 
o  Paralysis 
o  Paraesthesia 
o  Perishingly Cold  
•  Other symptoms:  
o  Atrophic skin  
o  Hairless 
o  Punched-out ulcers (often painful)  
o  Colour change when raising leg (to Buerger's angle)
151
Q

Investigations for peripheral vascular disease

A

• Full cardiovascular risk assessment
o Blood pressure
o FBC - anaemia will worsen ischaemia
o Fasting blood glucose
o Lipid levels
o ECG - check for pre-existing coronary artery disease o Thrombophilia screen - for patients < 50 yrs

• Colour Duplex Ultrasound o FIRST-line
o Shows site and degree of stenosis

• MRI/CT
o Assesses extent and location of stenoses

• ABPI (AnkleJBrachial Pressure Index)
o Marker of cardiovascular disease
o ABPI < 0.8 = do NOT apply a pressure bandage because this will worsen
ischaemia

152
Q

Define Pulmonary Hypertension

A

An increase in mean pulmonary arterial pressure which can be caused by or associated with a wide variety of other conditions

153
Q

Aetiology / Risk Factors of pulmonary hypertension

A

• Pulmonary hypertension has a variety of causes
o Idiopathic
o Problems with smaller branches of the pulmonary arteries
o Left ventricular failure
o Lung disease (e.g. COPD, interstitial lung disease)
o Thromboses/Emboli in the lungs

154
Q

Epidemiology of pulmonary hypertension

A
  • Idiopathic pulmonary hypertension is RARE

* More common in severe respiratory and cardiac disease

155
Q

Presenting symptoms of pulmonary hypertension

A
  • Progressive breathlessness
  • Weakness/tiredness
  • Exertional dizziness and syncope
  • LATE STAGE - oedema and ascites
  • Angina and tachyarrhythmia
156
Q

Signs of pulmonary hypertension on physical examination

A
  • Right ventricular heave
  • Loud pulmonary second heart sound
  • Murmur - pulmonary regurgitation
  • Tricuspid regurgitation
  • Raised JVP
  • Peripheral oedema
  • Ascites
157
Q

Investigations for pulmonary hypertension

A

• CXR - exclude other lung diseases
• ECG - right ventricular hypertrophy and strain
• Pulmonary function tests
• LFTs - liver damage –> portal hypertension
• Lung biopsy - interstitial lung disease
• Echocardiography - assess right ventricular function
• Right Heart Catheterisation - directly measure pulmonary pressure and confirm the
diagnosis

158
Q

Define Supraventricular Tachycardia (SVT)

A

A regular narrow-complex tachycardia (>100bpm) with no p waves and a supra ventricular origin
- AF technically counts as a type of SVT
- However SVT usually refers to:
• Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
• Atrioventricular Re-entry Tachycardia (AVRT)

159
Q

Aetiology/ Risk Factors of SVT

A
•  AVNRT 
o  A localised re-entry circuit forms around the AV node  
•  AVRT 
o  A re-entry circuit forms between the atria and ventricles due to the presence of 
an accessory pathway (Bundle of Kent)  
•  Risk Factors 
o  Nicotine  
o  Alcohol  
o  Caffeine  
o  Previous MI  
o  Digoxin toxicity
160
Q

Epidemiology of SVT

A
  • very common

- 2x more common in females

161
Q

Presenting symptoms of SVT

A
  • May have minimal symptoms or may present with syncope
  • Symptoms vary depending on rate and duration of SVT
  • Palpitations
  • Light-headedness
  • Abrupt onset and termination of symptoms
  • Other symptoms: fatigue, chest discomfort, dyspnoea, syncope
162
Q

Signs of SVT on physical examination

A

• AVNRT - normal except tachycardia
• Wolff-Parkinson-White
o Tachycardia
o Secondary cardiomyopathy (S3 gallop, RV heave, displaced apex beat)

163
Q

Investigations for SVT

A

• ECG
o Differentiating between AVNRT and AVRT - once the SVT has been terminated and normal rate and rhythm are re-established:
• AVNRT - appears normal
• AVRT - delta-waves (slurred upstroke of the QRS complex)
o 24 hr ECG monitoring -will be required in patients with paroxysmal palpitations
• Cardiac Enzymes
o Check for features of MI (especially if there is chest pain)
• Electrolytes - can cause arrhythmia
• TFTs - can cause arrhythmia
• Digoxin Level - for patients on digoxin
• Echocardiogram - check for structural heart disease

164
Q

Management plan for SVT

A

• If Haemodynamically UNSTABLE
o DC cardioversion

• If Haemodynamically STABLE –> vagal monouevres + chemical cardioversion
o Vagal manoeuvres (e.g. Valsalva, carotid massage)
• Carotid massage could dislodge atherosclerotic plaques, so is only performed in young patients
If Vagal manoeuvres fail:
o Adenosine 6 mg bolus (can increase to 12 mg)
• Contraindicated in ASTHMA as it can cause bronchospasm
o Can give verapamil 2.5 - 5 mg if unsuccessful/adenosine contraindicated due to asthma
o Alternatives: atenolol, amiodarone
• If unresponsive to chemical cardioversion or tachycardia > 250 bpm or adverse signs
(low BP, heart failure, low consciousness)
o Sedate and synchronised DC cardioversion
o Amiodarone
• Ongoing management of SVT
o AVNRT
• Radiofrequency ablation of slow pathway
• Beta-blockers
• Alternatives: fleicanide, propafenone, verapamil
o AVRT
• Radiofrequency ablation
o Sinus Tachycardia
• Exclude secondary cause (e.g. hyperthyroidism)
• Beta-blocker or rate-limiting CCB

165
Q

Complications of SVT

A
  • Haemodynamic collapse • DVT
  • Systemic embolism
  • Cardiac tamponade
166
Q

Prognosis for patients with SVT

A
  • Dependent on the presence of underlying structural heart disease
  • If structurally normal heart - GOOD PROGNOSIS
  • People with pre-excitation have a small risk of sudden death
167
Q

Define Tricuspid regurgitation

A

Backflow of blood from the right ventricle to the right atrium during systole

168
Q

Aetiology/ Risk factors for tricuspid regurgitation

A

• Congenital
o Ebstein’s anomaly (malpositioned tricuspid valve)
o Cleft valve in ostium primum
• Functional
o Consequence of right ventricular dilation (e.g. due to pulmonary hypertension) o Valve prolapse
• Rheumatic Heart Disease
• Infective Endocarditis
• Other: carcinoid syndrome, trauma, cirrhosis, iatrogenic

169
Q

Epidemiology of tricuspid regurgitation

A
  • Differs based on cause

* Infective endocarditis is the MOST COMMON cause

170
Q

Presenting symptoms of tricuspid regurgitation

A
  • Fatigue
  • Breathlessness
  • Palpitations
  • Headaches
  • Nausea
  • Anorexia
  • Epigastric pain made worse by exercise
  • Jaundice
  • Lower limb swelling
171
Q

Signs of tricuspid regurgitation on physical examination

A

• Pulse - irregularly irregular if AF
• Inspection
o Raised JVP with giant V waves (which may oscillate the earlobes)
o This is caused by transmission of high right ventricular pressures into the great
veins
o Giant A waves may also be present
• Palpation - parasternal heave
• Auscultation
o Pansystolic murmur - heard best at lower left sternal edge
o Louder on inspiration (Carvallo sign)
o Loud P2 component of second heart sound
• Chest Examination may show signs of:
o Pleural effusion
o Causes of pulmonary hypertension
• Abdominal Examination may show:
o Palpable liver (tender, smooth and pulsatile)
o Ascites
• Legs - pitting oedema

172
Q

Investigations for tricuspid reurgitation

A

• Bloods
o FBC
o LFT
o Cardiac enzymes
o Blood cultures
• ECG
o P pulmonale - due to right atrial hypertrophy
• CXR
o Right-sided enlargement of cardiac shadow
• Echocardiography
o Extent of regurgitation can be estimated using Doppler ultrasound
o May show valve prolapse and right ventricular dilation • Right Heart Catheterisation
o Rarely necessary but may be useful for assessing pulmonary artery pressure

173
Q

Define Varicose Veins

A

Veins that become prominently elongated, dilated and tortuous, most commonly the superficial veins of the lower limbs

174
Q

Aetiology/ Risk Factors of varicose veins

A
•  Primary 
o  Due to genetic or developmental weakness in the vein wall  
o  Results in increased elasticity, dilatation and valvular incompetence  
•  Secondary 
o  Due to venous outflow obstruction 
•  Pregnancy  
•  Pelvic malignancy 
•  Ovarian cysts  
•  Ascites  
•  Lymphadenopathy 
•  Retroperitoneal fibrosis  
o  Due to valve damage (e.g. after DVT) 
o  Due to high flow (e.g. arteriovenous fistula)   
•  RISK FACTORS 
o  Age  
o  Female  
o  Family history   
o  Caucasian 
o  Obesity
175
Q

Epidemiology of varicose veins

A
  • COMMON
  • Incidence increases with age
  • 10-15% of men
  • 20-25% of women
176
Q

Presenting symptoms of varicose veins

A
  • Patients may complain about the cosmetic appearance
  • Aching in the legs
  • Aching is worse towards the end of the day of after standing for long periods of time
  • Swelling
  • Itching
  • Bleeding
  • Infection
  • Ulceration
177
Q

Signs of varicose veins on physical examination

A

• Inspection
o Inspect when the patient is standing
• Palpation
o May feel fascial defects along the veins
o Cough impulse may be felt over the saphenofemoral junction
o Tap Test - tapping over the saphenofemoral junction will lead to an impulse felt
distally (this would not happen if the valves were competent)
o Palpation of a thrill or auscultation of a bruit would suggest an AV fistula
• Trendelenburg Test
o Allows localisation of the sites of valvular incompetence
o Leg is elevated and the veins are emptied
o A hand is placed over the saphenofemoral junction
o The leg is put back down and filling of the veins is observed before and after the
hand is released from the saphenofemoral junction
o A Doppler ultrasound can be used to show saphenofemoral incompetence
• Rectal or Pelvic Examination
o If secondary causes are suspected
• Signs of Venous Insufficiency
o Varicose eczema
o Haemosiderin staining
o Atrophie blanche
o Lipodermatosclerosis
o Oedema
o Ulceration

178
Q

Investigations for varicose veins

A

• Duplex Ultrasound
o Locates sites of incompetence or reflux
o Allows exclusion of DVT

179
Q

Management plan for varicose veins

A

• Conservative
o Exercise - improves skeletal muscle pump
o Elevation of legs at rest
o Support stockings
• Venous Telangiectasia and Reticular Veins
o Laser sclerotherapy
o Microinjection sclerotherapy
• Surgical
o Saphenofemoral ligation
o Stripping of the long saphenous vein
o Avulsion of varicosities
o NOTE: short saphenous vein isn’t stripped because of the risk of damaging the
sural nerve

180
Q

Complications of varicose veins

A

• Venous pigmentation
• Eczema
• Lipodermatosclerosis
• Superficial thrombophlebitis • Venous ulceration
• Complications of Treatment
o Sclerotherapy - skin staining, local scarring
o Surgery - haemorrhage, infection, recurrence, paraesthesia, peroneal nerve
injury

181
Q

Prognosis for patients with varicose veins

A
  • Slowly progressive

* High recurrence rates

182
Q

Define Vasovagal Syncope

A

Loss of consciousness due to a transient drop in blood flow to the brain caused by excessive vagal discharge

183
Q

Aetiology/ Risk Factors of vasovagal syncope

A
•  Vasovagal syncope is a very common cause of fainting   
•  Can be precipitated by: 
o  Emotions (e.g. fear, severe pain, blood phobia)  
o  Orthostatic stress (e.g. prolonged standing, hot weather)
184
Q

Epidemiology of vasovagal syncope

A
  • VERY COMMON

* Syncope (of all causes) affects 40% of people

185
Q

Presenting symptoms of vasovagal syncope

A

• Loss of consciousness lasting a short time
• Patients may experience vagal symptoms (sweating, dizziness, light-headedness)
before passing out
• There may be some twitching of limbs during the blackout
• Recovery is normally very quick

186
Q

Signs of vasovagal syncope on physical examination

A
  • Usually no signs
187
Q

Investigations for vasovagal syncope

A

• Investigations are involved with checking for other causes of syncope
o ECG - check for arrhythmia
o Echocardiogram - check for outflow obstruction
o Lying/standing blood pressure - check for orthostatic hypotension
o Fasting blood glucose - check for DM/hypoglycaemia

188
Q

Define Venous Ulcers

A

Large, shallow, sometimes painful ulcers usually found superior to the medial malleoli. They are caused by incompetent valves in the lower limbs leading to venous stasis and ulceration

189
Q

Aetiology/ Risk Factors of venous ulcers

A
•  They are caused by incompetent valves in the lower limbs  
•  Valve incompetence leads to venous stasis and increased venous pressure   •  This results in ulceration  
•  Risk Factors 
o  Obesity  
o  Immobility 
o  Recurrent DVT 
o  Varicose veins  
o  Previous injury/surgery to the leg   
o  Age
190
Q

Summarise the epidemiology of venous ulcers

A
  • VERY COMMON

* Increases with age

191
Q

Presenting symptoms of venous ulcers

A
•  Large, shallow, relatively painless ulcer with an 
irregular margin situated above the medial malleoli 
(most of the time)  
•  Features of the history: 
o  Varicose veins  
o  DVT  
o  Phlebitis  
o  Fracture, trauma or surgery   
o  Family history  
o  Other symptoms of venous insufficiency:  
•  Swelling 
•  Itching   
•  Aching
192
Q

Signs of venous ulcers on physical examination

A

• Other signs of venous ulcers:
o Stasis eczema
o Lipodermatosclerosis (inverted champagne bottle sign if SEVERE)
o Haemosiderin deposition (dark colour)

193
Q

Identify appropriate investigations for venous ulcers

A

• ABPI
o Exclude arterial ulcer
o If ABPI < 0.8 - do NOT apply a pressure bandage as this could worsen the ulcer
• Measure surface area of ulcer - allows monitoring of progression
• Swabs for microbiology - if signs of infection
• Biopsy - if possibility of Marjolin’s ulcer

194
Q

Management plan for venous ulcers

A

• Graduated compression (reduced venous stasis)
o NOTE: must exclude diabetes, neuropathy and PVD before this is attempted
• Debridement and cleaning
• Antibiotics - if infected
• Topical steroids - may help with surrounding dermatitis

195
Q

Complications of venous ulcers

A
  • Recurrence

* Infection

196
Q

Summarise the prognosis for patients with venous ulcers

A
  • GOOD

* Results are better if patients are mobile with few comorbidities

197
Q

Define Ventricular Fibrillation

A

An irregular broad-complex tachycardia that can cause cardiac arrest and sudden cardiac death

198
Q

Aetiology/ Risk Factors of ventricular fibrillation

A

• The ventricular fibres contract randomly causing complete failure of ventricular function
• Most cases occur in patients with underlying heart disease
• Risk Factors
o Coronary artery disease o AF
o Hypoxia
o Ischaemia
o Pre-excitation syndrome

199
Q

Epidemiology of ventricular fibrillation

A
  • The MOST COMMON arrhythmia identified in cardiac arrest patients
  • Incidence of VF parallels the incidence of ischaemic heart disease
200
Q

Presenting symptoms and signs of ventricular fibrillation

A
•  History of: 
o  Chest pain  
o  Fatigue  
o  Palpitations  
•  There may be known pre-existing conditions:  
o  Coronary artery disease  
o  Cardiomyopathy  
o  Valvular heart disease  
o  Long QT syndrome  
o  Wolff-Parkinson-White syndrome 
o  Brugada syndrome
201
Q

Investigations for ventricular fibrillation

A

• ECG
• Cardiac enzymes (e.g. troponins) - check for recent ischaemic event
• Electrolytes - derangement can cause arrhythmias, including VF
• Drug levels and toxicology screen - anti-arrhythmics can (ironically) cause arrhythmia,
as can various recreational drugs (e.g. cocaine)
• TFTs - hyperthyroidism can cause tachyarrhythmias
• Coronary angiography - if patient survives VF, to check the integrity of coronary
arteries

202
Q

Management plan for ventricular fibrillation

A

• VF requires urgent defibrillation and cardioversion
• Patients who survive need full assessment of left ventricular function, myocardial
perfusion and electrophysiological stability
• Most survivors will need an implantable cardioverter defibrillator (ICD)
• Empirical beta-blockers
• Some patients may be treated with radiofrequency ablation (RFA)

203
Q

Complications of ventricular fibrillation

A
  • Ischaemic brain injury due to loss of cardiac output
  • Myocardial injury
  • Post-defibrillation arrhythmias
  • Aspiration pneumonia
  • Skin burns
  • Death
204
Q

Prognosis for patients with ventricular fibrillation

A
  • Depends on the time between onset of VF and medical intervention
  • Early defibrillation is essential (ideally within 4-6 mins)
  • Anoxic encephalopathy is a major outcome of VF
205
Q

Define Ventricular Tachycardia

A

A regular broad-complex tachycardia originating from a ventricular ectopic focus. The rate is usually >120bpm

206
Q

Aetiology/ Risk Factors of ventricular tachycardia

A

• Electrical impulses arise from a ventricular ectopic focus
• Risk Factors
o Coronary heart disease
o Structural heart disease
o Electrolyte deficiencies (e.g. hypokalaemia, hypocalcaemia, hypomagnesaemia)
o Use of stimulant drugs (e.g. caffeine, cocaine)

207
Q

Epidemiology of ventricular tachycardia

A
  • Fairly common
  • It is one of the shockable rhythms that is seen in cardiac arrest patients
  • VT incidence peaks in the middle decades of life
208
Q

Presenting symptoms of ventricular tachycardia

A
•  Symptoms of ischaemic heart disease or haemodynamic compromise due to poor  perfusion  
•  Symptoms: 
o  Chest pain  
o  Palpitations   
o  Dyspnoea   
o  Syncope
209
Q

Signs of ventricular tachycardia on physical examination

A
•  Signs are dependent on the degree of haemodynamic instability 
o  Respiratory distress  
o  Bibasal crackles  
o  Raised JVP  
o  Hypotension 
o  Anxiety  
 o  Agitation  
o  Lethargy  
o  Coma
210
Q

Investigations for ventricular tachycardia

A

• ECG
o It can sometimes be difficult to distinguish between VT and SVT with aberrant
conduction
o If in doubt, treat as a VT o ECG Features:
• Rate > 100 bpm
• Broad QRS complexes
• AV dissociation
• Electrolytes - derangement can cause arrhythmias
• Drug levels - e.g. check for digoxin toxicity
• Cardiac enzymes - e.g. troponins to check for recent ischaemic event

211
Q

Management plan for ventricular tachycardia

A

• ABC approach
• CHECK WHETHER THE PATIENT HAS A PULSE OR NOT
• Pulseless VT - follow advanced life support algorithm
• Unstable VT - reduced cardiac output
NOTE: VF and pulseless VT require defibrillation (unsynchronised), but other VTs can be treated with synchronised cardioversion
o Correct electrolyte abnormalities
o Amiodarone

• Stable VT
o These patients DO NOT experience symptoms of haemodynamic compromise o Correct electrolyte abnormalities
o Amiodarone
o Synchronised DC shock (if steps above are unsuccessful)

• Implantable Cardioverter Defibrillator (ICD)
o ICD is considered if:
• Sustained VT causing syncope
• Sustained VT with ejection fraction < 35%
• Previous cardiac arrest due to VT or VF
• MI complicated by non-sustained VT

212
Q

Complications of ventricular tachycardia

A
  • Congestive cardiac failure • Cardiogenic shock

* VT may deteriorate into VF

213
Q

Prognosis of ventricular tachycardia

A
  • GOOD if treated RAPIDLY

* Long-term prognosis depends on the underlying cause

214
Q

Define Wolff-Parkinson-Whie Syndrome

A

A congenital abnormality which can result in supra ventricular tachycardias that use an accessory pathway. It’s a pre-excitation syndrome

215
Q

Aetiology/ Risk Factors of WPW syndrome

A

• The accessory pathway (bundle of Kent) is likely to be congenital
• Associations:
o Congenital cardiac defects
o Ebstein’s anomaly (congenital malformation of the heart characterised by
displacement of septal and posterior tricuspid leaflets) o Mitral valve prolapse
o Cardiomyopathies (e.g. HOCM)

216
Q

Epidemiology of WPW syndrome

A
  • Relatively COMMON
  • Most common of the ventricular pre-excitation syndromes
  • Found in ALL AGES
  • More common in the YOUNG
  • Prevalence decreases with age
217
Q

Presenting symptoms and signs of WPW syndrome

A

• SVT may occur in early childhood
• Often ASYMPTOMATIC - may be an incidental finding of an ECG
• Symptoms:
o Palpitations
o Light-headedness
o Syncope
• Paroxysmal SVT may be followed by a period of polyuria, due to atrial dilatation and release of ANP
• Sudden death - if SVT deteriorates into VF
• Clinical features of associated cardiac defects (e.g. mitral valve prolapse,
cardiomyopathy)

218
Q

Investigations for WPW syndrome

A

• ECG may be normal if the conduction speed of the impulse along the accessory
pathway matches the conduction speed down the bundle of His
• Classic ECG findings:
o Short PR interval
o Broad QRS complex
o Slurred upstroke producing a delta wave
• Patient may be in SVT (AVRT)
• Bloods - check for other causes of arrhythmia
• Echocardiogram - check for structural heart defects